The Oxford-AstraZeneca is hailed as a cheap and easy jab to fight COVID-19. But a series of corporate stumbles have clouded it's promise, and science backed results.
AstraZeneca's self-inflicted wounds | Front Burner podcast - Listen or read transcript on Metacast